Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:SIBN

SiBone Q3 2026 Earnings Date & Estimates

SiBone logo
$21.48 -0.08 (-0.37%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$21.47 -0.01 (-0.05%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SiBone is estimated to report Q3 2026 earnings on Monday, November 2, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from SiBone in Q3 2026

SiBone is expected to post earnings of -$0.13 per share on revenue of $55.31 million. In the same quarter a year earlier SiBone reported -$0.11 per share on revenue of $48.66 million. SiBone last reported on August 3, 2026, posting -$0.09 per share and beating the -$0.1495 consensus estimate. SiBone has beaten the consensus EPS estimate in 8 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.13
Expected Revenue
$55.31 million
Prior-Year EPS
-$0.11
Prior-Year Revenue
$48.66 million
Expected Revenue Growth
+13.7%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.09 (Beat by +$0.0595)
Last Quarter Revenue
$56.01 million
EPS Beat Rate
8 of last 8 quarters

Prepare for the Q3 2026 Call

SiBone Q3 2026 Earnings FAQ

SiBone (NASDAQ:SIBN) is estimated to report Q3 2026 earnings on Monday, November 2, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

SiBone's Q3 2026 earnings conference call is scheduled for Monday, November 2, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect SiBone to post earnings of -$0.13 per share for Q3 2026.

The consensus revenue estimate for SiBone is $55.31 million for Q3 2026.

SiBone Earnings Headlines

SiBone (NASDAQ:SIBN) Stock Now Rated "Moderate Buy" by Sell-Side Analysts
October 23 at 2:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31148305
SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026
October 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/19/3383885/0/en/si-bone-to-report-third-quarter-2026-financial-results-on-november-2-2026.html
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live.tc pixel
October 24 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Truist Financial Forecasts Strong Price Appreciation for SiBone (NASDAQ:SIBN) Stock
October 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31123630
Is SI-BONE Inc (SIBN) Overvalued After 3.8% Rally? GF Value Says Overvalued
October 12, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9120211/is-sibone-inc-sibn-overvalued-after-38-rally-gf-value-says-overvalued
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx, Extending Its Compromised Bone Franchise Beyond the Pelvis
September 29, 2026  |  marketscreener.comM
See More SiBone Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SiBone? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SiBone and other key companies, straight to your email.

About SiBone

SI-BONE, Inc. (NASDAQ: SIBN) is a medical device company focused on diagnosing and treating disorders of the sacroiliac joint, which connects the spine to the pelvis. The company develops minimally invasive surgical solutions intended to stabilize the sacroiliac joint and address sacroiliac joint dysfunction and related conditions.

Its product portfolio is centered on the iFuse Implant System, a family of triangular implants designed to be placed across the sacroiliac joint. SI-BONE also offers products such as iFuse-TORQ, a threaded implant system, and iFuse Bedrock Granite, which is designed for sacroiliac joint fusion and pelvic fixation as part of certain spinal procedures. The company provides associated instruments and surgical technologies to support these procedures.

Founded in 2008 and headquartered in Santa Clara, California, SI-BONE markets its products primarily in the United States and also serves select international markets. Its solutions are used by spine and orthopedic surgeons in hospitals and other surgical settings. SI-BONE became a publicly traded company in 2018.

View SiBone Profile
Earnings Tools